Literature DB >> 33859358

A unified model of the pathophysiology of bipolar disorder.

Paola Magioncalda1,2,3, Matteo Martino4,5.   

Abstract

This work provides an overview of the most consistent alterations in bipolar disorder (BD), attempting to unify them in an internally coherent working model of the pathophysiology of BD. Data on immune-inflammatory changes, structural brain abnormalities (in gray and white matter), and functional brain alterations (from neurotransmitter signaling to intrinsic brain activity) in BD were reviewed. Based on the reported data, (1) we hypothesized that the core pathological alteration in BD is a damage of the limbic network that results in alterations of neurotransmitter signaling. Although heterogeneous conditions can lead to such damage, we supposed that the main pathophysiological mechanism is traceable to an immune/inflammatory-mediated alteration of white matter involving the limbic network connections, which destabilizes the neurotransmitter signaling, such as dopamine and serotonin signaling. Then, (2) we suggested that changes in such neurotransmitter signaling (potentially triggered by heterogeneous stressors onto a structurally-damaged limbic network) lead to phasic (and often recurrent) reconfigurations of intrinsic brain activity, from abnormal subcortical-cortical coupling to changes in network activity. We suggested that the resulting dysbalance between networks, such as sensorimotor networks, salience network, and default-mode network, clinically manifest in combined alterations of psychomotricity, affectivity, and thought during the manic and depressive phases of BD. Finally, (3) we supposed that an additional contribution of gray matter alterations and related cognitive deterioration characterize a clinical-biological subgroup of BD. This model may provide a general framework for integrating the current data on BD and suggests novel specific hypotheses, prompting for a better understanding of the pathophysiology of BD.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 33859358     DOI: 10.1038/s41380-021-01091-4

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  102 in total

Review 1.  Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites.

Authors:  George Anderson; Michael Maes
Journal:  Curr Psychiatry Rep       Date:  2015-02       Impact factor: 5.285

2.  Low natural killer cytotoxicity in major depression.

Authors:  M Irwin; T L Smith; J C Gillin
Journal:  Life Sci       Date:  1987-11-02       Impact factor: 5.037

Review 3.  Large-scale brain networks and psychopathology: a unifying triple network model.

Authors:  Vinod Menon
Journal:  Trends Cogn Sci       Date:  2011-09-09       Impact factor: 20.229

4.  Immunological aspects of bipolar disorder.

Authors:  R W Kupka; M H Hillegers; W A Nolen; N Breunis; H A Drexhage
Journal:  Acta Neuropsychiatr       Date:  2000-09       Impact factor: 3.403

Review 5.  Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide.

Authors:  Jonathan Savitz; Wayne C Drevets
Journal:  Neurosci Biobehav Rev       Date:  2009-01-21       Impact factor: 8.989

6.  Impaired lymphocyte stimulation by mitogens in severely depressed patients. A complex interface with HPA-axis hyperfunction, noradrenergic activity and the ageing process.

Authors:  M Maes; E Bosmans; E Suy; B Minner; J Raus
Journal:  Br J Psychiatry       Date:  1989-12       Impact factor: 9.319

Review 7.  In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.

Authors:  Susanne Nikolaus; Christina Antke; Hans-Wilhelm Müller
Journal:  Behav Brain Res       Date:  2009-06-10       Impact factor: 3.332

Review 8.  All roads lead to the motor cortex: psychomotor mechanisms and their biochemical modulation in psychiatric disorders.

Authors:  Paola Magioncalda; Matteo Martino; Georg Northoff; Dusan Hirjak; Robert C Wolf
Journal:  Mol Psychiatry       Date:  2020-06-17       Impact factor: 15.992

Review 9.  Clinical application of brain imaging for the diagnosis of mood disorders: the current state of play.

Authors:  J B Savitz; S L Rauch; W C Drevets
Journal:  Mol Psychiatry       Date:  2013-04-02       Impact factor: 15.992

Review 10.  Neuropathology of mood disorders: do we see the stigmata of inflammation?

Authors:  N Mechawar; J Savitz
Journal:  Transl Psychiatry       Date:  2016-11-08       Impact factor: 6.222

View more
  3 in total

Review 1.  Combination Olanzapine and Samidorphan for the Management of Schizophrenia and Bipolar 1 Disorder in Adults: A Narrative Review.

Authors:  Hannah W Haddad; Elena Boardman; Brooke Williams; Rama Mouhaffel; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-04-25

2.  Cerebrospinal fluid proteomic study of two bipolar disorder cohorts.

Authors:  Anniella Isgren; Andreas Göteson; Jessica Holmén-Larsson; Aurimantas Pelanis; Carl Sellgren; Erik Joas; Timea Sparding; Henrik Zetterberg; Erik Smedler; Joel Jakobsson; Mikael Landén
Journal:  Mol Psychiatry       Date:  2022-08-19       Impact factor: 13.437

3.  Identifying transdiagnostic biological subtypes across schizophrenia, bipolar disorder, and major depressive disorder based on lipidomics profiles.

Authors:  Shiwan Tao; Yamin Zhang; Qiang Wang; Chunxia Qiao; Wei Deng; Sugai Liang; Jinxue Wei; Wei Wei; Hua Yu; Xiaojing Li; Mingli Li; Wanjun Guo; Xiaohong Ma; Liansheng Zhao; Tao Li
Journal:  Front Cell Dev Biol       Date:  2022-09-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.